Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Adler

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Neurology|February 11, 2000
A kindred with Parkinson's disease not showing genetic linkage to established lociK A Gwinn-Hardy, R Crook, S Lincoln, et al.
Muscle & Nerve|November 1, 1994
Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoproteinA Pestronk, R Choksi, K Bieser, et al.
Parkinsonism & Related Disorders|May 12, 2005
Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?M N Sabbagh, N Silverberg, S Bircea, et al.
Acta Neurologica Scandinavica|October 26, 2010
Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's diseaseV G H Evidente, A P Premkumar, C H Adler, et al.
Neurology|April 28, 2004
Ropinirole for restless legs syndrome: a placebo-controlled crossover trialC H Adler, R A Hauser, K Sethi, et al.
Neurology|July 1, 1992
Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's diseaseH Arai, M L Schmidt, V M Lee, et al.
Neurology|March 4, 1998
Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patientsK M Shannon, R D Penn, J S Kroin, et al.
Neurology|April 17, 2008
Pathologic findings in prospectively ascertained essential tremor subjectsH A Shill, C H Adler, M N Sabbagh, et al.
Brain Research|November 7, 2002
Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptorsJ N Joyce, H L Ryoo, T B Beach, et al.
NPJ Parkinson'S Disease|April 5, 2025
Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohortL M Chahine, M C Brumm, A R Nair, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Neurology|February 11, 2000
A kindred with Parkinson's disease not showing genetic linkage to established lociK A Gwinn-Hardy, R Crook, S Lincoln, et al.
Muscle & Nerve|November 1, 1994
Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoproteinA Pestronk, R Choksi, K Bieser, et al.
Parkinsonism & Related Disorders|May 12, 2005
Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?M N Sabbagh, N Silverberg, S Bircea, et al.
Acta Neurologica Scandinavica|October 26, 2010
Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's diseaseV G H Evidente, A P Premkumar, C H Adler, et al.
Neurology|April 28, 2004
Ropinirole for restless legs syndrome: a placebo-controlled crossover trialC H Adler, R A Hauser, K Sethi, et al.
Neurology|July 1, 1992
Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's diseaseH Arai, M L Schmidt, V M Lee, et al.
Neurology|March 4, 1998
Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patientsK M Shannon, R D Penn, J S Kroin, et al.
Neurology|April 17, 2008
Pathologic findings in prospectively ascertained essential tremor subjectsH A Shill, C H Adler, M N Sabbagh, et al.
Brain Research|November 7, 2002
Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptorsJ N Joyce, H L Ryoo, T B Beach, et al.
NPJ Parkinson'S Disease|April 5, 2025
Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohortL M Chahine, M C Brumm, A R Nair, et al.
Pageof 8